STOCK TITAN

Inspire Medical SEC Filings

INSP NYSE

Welcome to our dedicated page for Inspire Medical SEC filings (Ticker: INSP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Evaluating a company built around an implantable sleep-apnea device means combing through pages of clinical data, FDA correspondence, and reimbursement notes. Inspire Medical Systems’ filings can feel like a medical journal, yet missing a single update on trial results or executive trades can sway your view of INSP’s value.

Stock Titan’s AI bridges that gap. Our platform ingests every document the moment it hits EDGAR, from a routine Inspire Medical Systems quarterly earnings report 10-Q filing to the surprise Inspire Medical Systems 8-K material events explained. Instant, plain-English summaries highlight growth in implant procedures, new CMS coverage decisions, and supply-chain disclosures—turning technical paragraphs into clear takeaways.

Use cases investors ask for every quarter are built in:

  • Follow Inspire Medical Systems insider trading Form 4 transactions and receive alerts on Inspire Medical Systems Form 4 insider transactions real-time before the market closes.
  • Dive into an Inspire Medical Systems annual report 10-K simplified to see unit economics on each neurostimulator sold.
  • Compare R&D spending with revenue in our Inspire Medical Systems earnings report filing analysis.

Need context fast? Ask in plain language—“understanding Inspire Medical Systems SEC documents with AI” or “Inspire Medical Systems proxy statement executive compensation”—and the system surfaces the exact table or chart. Whether you’re tracking Inspire Medical Systems executive stock transactions Form 4 or verifying how many centers are implanting the device, you’ll find every disclosure, timestamped and explained simply.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Inspire Medical (INSP)?

The current stock price of Inspire Medical (INSP) is $126.83 as of July 18, 2025.

What is the market cap of Inspire Medical (INSP)?

The market cap of Inspire Medical (INSP) is approximately 4.1B.

What is the primary focus of Inspire Medical Systems?

Inspire Medical Systems specializes in developing minimally invasive neurostimulation therapies for patients with obstructive sleep apnea, providing an alternative to traditional treatments.

How does Inspire Medical generate revenue?

The company generates revenue chiefly through the sales and distribution of its proprietary neurostimulation devices, supported by robust research and development and strategic market penetration in key regions.

What makes Inspire Medical's technology innovative?

The innovation lies in its minimally invasive neurostimulation system, which leverages advanced technology to activate natural physiological functions and effectively treat sleep apnea.

What regulatory approvals has the company achieved?

Inspire Medical has received major regulatory approvals including FDA clearance and compliance with the EU Medical Device Regulation (EU MDR), demonstrating the safety and effectiveness of its technology.

In which markets does Inspire Medical operate?

The company primarily serves the United States and European markets, with a significant operational footprint that enhances its global presence in the medical device industry.

How does Inspire Medical ensure product quality?

Quality is maintained through rigorous clinical testing, strict adherence to international regulatory standards, and continuous improvements in its production and quality assurance processes.

How does the company differentiate itself from competitors?

Inspire Medical differentiates itself through its unique focus on minimally invasive neurostimulation, proven clinical efficacy, comprehensive regulatory compliance, and the integration of advanced imaging compatibility.

What role does clinical evidence play in Inspire Medical's strategy?

Clinical evidence is central to the company’s strategy, providing strong validation for its treatment efficacy, influencing reimbursement decisions, and supporting market adoption of its neurostimulation therapy.
Inspire Medical

NYSE:INSP

INSP Rankings

INSP Stock Data

4.11B
27.83M
2.15%
115.59%
10.58%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
GOLDEN VALLEY